Complete Story


Pfizer COVID-19 Vaccine 90 Percent Effective at Preventing Hospitalization

Study finds this is even the case against the delta variant

The Pfizer COVID-19 vaccine remains 90 percent effective at reducing a person's risk of hospitalization from the virus six months after it is administered, a new study has found. This is true even in the face of the delta variant as well as if the person has not received a booster shot.

Still, when it comes to preventing infections, the vaccine's effectiveness wanes rapidly as time passes, the study found. After five months, it is just 47 percent effective at preventing infection.

In the study, funded by Pfizer, researchers assessed data from Kaiser Permanente and calculated the percentages of fully vaccinated patients who contracted COVID-19 on a monthly basis after vaccination. Data from roughly 3.4 million people was analyzed between December 2020 and August 2021.

Please select this link to read the complete article from ABC News.

Printer-Friendly Version